JWM
KRYS icon

JPL Wealth Management’s Krystal Biotech KRYS Stock Holding History

JPL Wealth Management’s Portfolio KRYS Stock Details KRYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.58K Buy
+10
New +$2.66K ﹤0.01% 894
2025
Q4 		– Sell
-10
Closed -$1.77K – 657
2025
Q3 		$1.77K Buy
+10
New +$1.5K ﹤0.01% 884

Other funds holding KRYS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JPL Wealth Management's KRYS Position: Q1 2026 in Review

JPL Wealth Management opened a new position in Krystal Biotech (KRYS) in Q1 2026: 10 shares worth $2.58K. The stake represents ﹤0.01% of the portfolio and ranks #894 among its holdings. This is a return to the name: JPL Wealth Management previously reported a position in KRYS as recently as Q3 2025.

JPL Wealth Management first reported a position in KRYS in Q3 2025 and has held it in 2 quarters since. 367 funds tracked by Wall St. Rank hold KRYS as of Q1 2026.

  • JPL Wealth Management held 10 shares of Krystal Biotech worth $2.58K as of Q1 2026.
  • Krystal Biotech was a new JPL Wealth Management position in Q1 2026.
  • Krystal Biotech made up ﹤0.01% of JPL Wealth Management's portfolio in Q1 2026, its #894 holding.
  • JPL Wealth Management first reported a position in Krystal Biotech in Q3 2025 and has held it in 2 quarters since.
  • 367 funds tracked by Wall St. Rank held Krystal Biotech as of Q1 2026.

Based on JPL Wealth Management's 13F filing for Q1 2026, filed 8 May 2026.